Apos Medical and Sports Technology Ltd.
7
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement
Role: collaborator
The Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain
Role: collaborator
The Effect of Footwear Generated Biomechanical Manipulation on Symptoms of Stress Urinary Incontinence
Role: collaborator
The Effect of AposTherapy on Knee Pain
Role: collaborator
APOS Therapy for Osteoarthritis of the Knee: a Randomized Controlled Trial BIOTOK
Role: collaborator
AposTherapy for Singaporean Patients With Knee Osteoarthritis (OA)
Role: lead
The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders
Role: collaborator
All 7 trials loaded